Document Detail


Refractory no-reflow successfully treated with local infusion of high-dose adenosine and verapamil--a case report.
MedLine Citation:
PMID:  11228087     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
No-reflow is an unpredictable complication following percutaneous coronary intervention. No-reflow is associated with myocardial ischemia and infarction and increased mortality. A case of refractory no-reflow is described that was rapidly and successfully treated with multiple infusions of high doses of verapamil and adenosine applied directly at the site of no-reflow through a perfusion catheter.
Authors:
W C Dillon; D Hadian; M E Ritchie
Related Documents :
23673907 - Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/c...
24826247 - Two-point left ventricle pacing and cardiac computed tomography.
16002157 - Prognostic value of interleukin-8 as a predictor of heart failure in patients with myoc...
23709657 - Coronary collaterals predict improved survival and allograft function in patients with ...
3704697 - Myocardial damage and electrical injuries: significance of early elevation of cpk-mb is...
9875127 - Raised factor viii is associated with coronary thrombotic events.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Angiology     Volume:  52     ISSN:  0003-3197     ISO Abbreviation:  Angiology     Publication Date:  2001 Feb 
Date Detail:
Created Date:  2001-02-28     Completed Date:  2001-03-29     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0203706     Medline TA:  Angiology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  137-41     Citation Subset:  IM    
Affiliation:
Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis 46202, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenosine / administration & dosage*,  therapeutic use
Angioplasty, Transluminal, Percutaneous Coronary
Coronary Angiography
Coronary Circulation
Coronary Disease / drug therapy,  therapy*
Heart Catheterization
Humans
Infusions, Intra-Arterial
Male
Middle Aged
Vasodilator Agents / administration & dosage*,  therapeutic use
Verapamil / administration & dosage*,  therapeutic use
Chemical
Reg. No./Substance:
0/Vasodilator Agents; 52-53-9/Verapamil; 58-61-7/Adenosine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparison between isosorbide dinitrate in aerosol and in tablets for the treatment of hypertensive ...
Next Document:  Exercise-induced left bundle branch block during thallium 201 myocardial perfusion scintigraphy--a c...